ArticleCell death & disease2014

Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1).

J Diessner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.